196 related articles for article (PubMed ID: 31410813)
21. Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Breast Cancer Res Treat; 2017 Nov; 166(1):145-156. PubMed ID: 28702891
[TBL] [Abstract][Full Text] [Related]
22. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
23. Utilization of breast cancer screening with magnetic resonance imaging in community practice.
Hill DA; Haas JS; Wellman R; Hubbard RA; Lee CI; Alford-Teaster J; Wernli KJ; Henderson LM; Stout NK; Tosteson ANA; Kerlikowske K; Onega T
J Gen Intern Med; 2018 Mar; 33(3):275-283. PubMed ID: 29214373
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with imaging and procedural events used to detect breast cancer after screening mammography.
Carney PA; Abraham LA; Miglioretti DL; Yabroff KR; Sickles EA; Buist DS; Kasales CJ; Geller BM; Rosenberg RD; Dignan MB; Weaver DL; Kerlikowske K;
AJR Am J Roentgenol; 2007 Feb; 188(2):385-92. PubMed ID: 17242246
[TBL] [Abstract][Full Text] [Related]
25. Determination of recall rates for assessment in high-risk women undergoing annual surveillance breast MRI.
Healy NA; O'Keeffe SA
Clin Radiol; 2016 Nov; 71(11):1143-7. PubMed ID: 27542654
[TBL] [Abstract][Full Text] [Related]
26. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
[TBL] [Abstract][Full Text] [Related]
27. Breast magnetic resonance imaging for surveillance of women with a personal history of breast cancer: outcomes stratified by interval between definitive surgery and surveillance MR imaging.
Park VY; Kim EK; Kim MJ; Moon HJ; Yoon JH
BMC Cancer; 2018 Jan; 18(1):91. PubMed ID: 29357842
[TBL] [Abstract][Full Text] [Related]
28. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
[TBL] [Abstract][Full Text] [Related]
29. Semiannual Breast US or MRI Screening in Patients with a Personal History of Breast Cancer.
Ha SM; Lee JM; Kim SO; Moon WK; Chang JM
Radiology; 2023 Jun; 307(5):e221660. PubMed ID: 37158719
[TBL] [Abstract][Full Text] [Related]
30. Under utilization of surveillance mammography among older breast cancer survivors.
Field TS; Doubeni C; Fox MP; Buist DS; Wei F; Geiger AM; Quinn VP; Lash TL; Prout MN; Yood MU; Frost FJ; Silliman RA
J Gen Intern Med; 2008 Feb; 23(2):158-63. PubMed ID: 18060463
[TBL] [Abstract][Full Text] [Related]
31. Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01).
Adesoye T; Schumacher JR; Neuman HB; Edge S; McKellar D; Winchester DP; Francescatti AB; Greenberg CC;
Ann Surg Oncol; 2018 Jun; 25(6):1502-1511. PubMed ID: 29450753
[TBL] [Abstract][Full Text] [Related]
32. Positive predictive value of screening mammography by age and family history of breast cancer.
Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
[TBL] [Abstract][Full Text] [Related]
33. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
34. Detection of ductal carcinoma in situ in women undergoing screening mammography.
Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
[TBL] [Abstract][Full Text] [Related]
35. Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.
Stout NK; Nekhlyudov L; Li L; Malin ES; Ross-Degnan D; Buist DS; Rosenberg MA; Alfisher M; Fletcher SW
JAMA Intern Med; 2014 Jan; 174(1):114-21. PubMed ID: 24247482
[TBL] [Abstract][Full Text] [Related]
36. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation.
Kerlikowske K; Grady D; Barclay J; Sickles EA; Ernster V
JAMA; 1996 Jul; 276(1):39-43. PubMed ID: 8667537
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
Stoutjesdijk MJ; Boetes C; Jager GJ; Beex L; Bult P; Hendriks JH; Laheij RJ; Massuger L; van Die LE; Wobbes T; Barentsz JO
J Natl Cancer Inst; 2001 Jul; 93(14):1095-102. PubMed ID: 11459871
[TBL] [Abstract][Full Text] [Related]
39. A Mixed Method Approach to Examine Surveillance Mammography Experiences in Black and White Breast Cancer Survivors.
Edmonds MC; Kim SJ; Wells M; Dahman B; Sheppard VB
Clin Breast Cancer; 2022 Dec; 22(8):801-811. PubMed ID: 36137937
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
